alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### STATE of Louisiana v. Raymond J. MOORE.

No. 53501.

Supreme Court of Louisiana.

Sept. 24, 1973.

J. Lyle DeBellevue, Crowley, for defendant-appellant.

William J. Guste, Jr., Atty. Gen., LeRoy A. Hartley, Special Asst. Atty. Gen., J. Nathan Stansbury, Dist. Atty., Robert T. Clime, Asst. Dist. Atty., for plaintiff-appel-lee.

DIXON, Justice.

Defendant-appellant Raymond J. Moore was indicted and tried for the crime of murder. The jury returned a responsive verdict of guilty of manslaughter, and defendant was sentenced to serve ten years at hard labor in the state penitentiary. Defendant has appealed to this court to obtain a reversal of his conviction and sentence.

No bills of exceptions were perfected to this court and apparently none were reserved at trial. We are therefore limited in our review to errors discoverable by a mere inspection of the pleadings and proceedings without inspection of the evidence. C.Cr.P. 920.

In brief before this court, defense counsel on appeal (appointed after trial, and not trial counsel) alleges that a key prosecution witness perjured himself during trial and that the district attorney was allowed to introduce evidence of a prior arrest which did not result in a conviction, all to the extreme prejudice of the defend*244ant. These are evidentiary matters which can be considered by us only in connection with perfected bills of exceptions.

We have carefully inspected the record of this case and do not find any errors patent on the face of the record which would require that we reverse this conviction and sentence.

The conviction and sentence are therefore affirmed.
<PAGE>   1
                                                                   EXHIBIT 24.13

                               POWER OF ATTORNEY


                 KNOW ALL MEN BY THESE PRESENTS,  that Stanley C. Peterson, a
member of the Board of Directors of ML Life Insurance Company of New York (the
"Company"), whose signature appears below, constitutes and appoints Barry G.
Skolnick and Michael P.  Cogswell, respectively, and each of them, his true and
lawful attorney-in-fact and agent, with full power of substitution and
resubstitution, for him and in his name, place and stead, in any and all
capacities, to sign any and all Registration Statements and Amendments thereto,
and to file the same, with all exhibits thereto, and other documents in
connection therewith, under the Investment Company Act of 1940, where
applicable, and the Securities Act of 1933, respectively, with the Securities
and Exchange Commission, for the purpose of registering any and all variable
life and variable annuity separate accounts (collectively "Separate Accounts"),
of the Company that may be established in connection with the issuance of any
and all variable life and variable annuity contracts funded by such Separate
Accounts, granting unto said attorney-in-fact and agent, and each of them, full
power and authority to do and perform each and every act and thing requisite
and necessary to be done.


              Date:                      /s/ Stanley C. Peterson      .
                                        ------------------------------------
                                        Stanley C. Peterson
---

State of New Jersey       )
County of Middlesex       )

                 On the 17th day of March, 1998, before me came Stanley C.
Peterson, Director of ML Life Insurance Company of New York, to me known to be
said person and he signed the above Power of Attorney on behalf of ML Life
Insurance Company of New York.



                                        /s/ Carol ElSayed
                                        ---------------------------------
                 [SEAL]                 Notary Public
#### Donald STEVENSON, Appellant, v. Laverne STEVENSON, Appellee.

No. 73-415.

District Court of Appeal of Florida, Third District.

Dec. 21, 1973.

Helen Taños Hope, Miami, Richard H. W. Maloy, Coral Gables, for appellant.

Schwartz & Wayner, Miami, for appel-lee.

Before PEARSON, HENDRY and HAVERFIELD, JJ.

PER CURIAM.

Affirmed. See Christianson v. Christianson, Fla.App.1973, 274 So.2d 562; King v. King, Fla.App.1973, 271 So.2d 159; Stamm v. Stamm, Fla.App.1972, 266 So.2d 413; Gunter v. Gunter, Fla.App.1969, 219 So.2d 743; Black v. Miller, Fla.App. 1969, 219 So.2d 106.
**Exhibit 32****Certification of CEO and CFO Pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 905of the Sarbanes-Oxley Act of 2002**In connection with the Annual Report of Swift Transportation Co., Inc. (the “Company”) for theperiod ended December 31, 2005 as filed on Form 10-K with the Securities and Exchange Commission onthe date hereof (the “Report”), each of the undersigned certifies, pursuant to 18 U.S.C. section1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of hisor her knowledge: (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and(2) The information contained in the Report fairly presents, in all material respects, the financial condition andresults of operations of the Company.   Date:March 6, 2006     /s/ Robert W. Cunningham     Robert W. Cunningham  Chief Executive Officer and President  (Principal Executive Officer)     /s/ Glynis A. Bryan     Glynis A. Bryan  Chief Financial Officer  (Principal Financial Officer)  This certification is being furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 andshall not be deemed filed by the Registrant as part of the Annual Report in Form 10-K.
[Federal Register Volume 62, Number 249 (Tuesday, December 30, 1997)]
[Notices]
[Page 67878]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-33794]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration
[Docket No. 97N-0401]


Agency Information Collection Activities; Announcement of OMB 
Approval

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Export of Medical Devices--Foreign 
Letters of Approval'' has been approved by the Office of Management and 
Budget (OMB) under the Paperwork Reduction Act of 1995 (the PRA).

FOR FURTHER INFORMATION CONTACT: Margaret R. Schlosburg, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1223.

SUPPLEMENTARY INFORMATION: In the Federal Register of October 3, 1997 
(62 FR 51872), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 
section 3507 of the PRA (44 U.S.C. 3507). An agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number. 
OMB has now approved the information collection and has assigned OMB 
control number 0910-0264. The approval expires on November 30, 2000.

    Dated: December 18, 1997.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 97-33794 Filed 12-29-97; 8:45 am]
BILLING CODE 4160-01-F
#### Joe COBB v. STATE of Florida.

No. 39410.

Supreme Court of Florida.

Jan. 1970.

Habeas Corpus denied without opinion.
----

**Exhibit        32.1**

| (1)    | The                  Report fully complies with the requirements of section 13(a) or                  15(d) of                  the Securities Exchange Act of 1934; and                               |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                   |
| (2)    | The                  information contained in the Report fairly presents, in all material                  respects, the financial condition and result of operations of the                  Company. |

|   | /s/                  Harold F. Herron |   |
|--------|---------------------------------------|--------|
|   | Harold                  F. Herron,    |   |
|   | President                             |   |
|   | August                  11, 2005      |   |
United States Court of Appeals

FOR THE DISTRICT OF COLUMBIA CIRCUIT

____________

No. 21-5175 September Term, 2021

1:21-cv-01389-UNA

Filed On: November 29, 2021

Yan-Xu Lu, formerly known as Yung-Kai Lu,

Appellant

v.

Allison H. Eid and Clark Waddoups,

Appellees

ON APPEAL FROM THE UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF COLUMBIA

BEFORE: Rao and Walker, Circuit Judges, and Sentelle, Senior Circuit Judge

J U D G M E N T

This appeal was considered on the record from the United States District Court

for the District of Columbia and on the brief filed by appellant. See Fed. R. App. P.

34(a)(2); D.C. Cir. Rule 34(j). It is

ORDERED AND ADJUDGED that the district court’s July 12, 2021 order

dismissing the case with prejudice be affirmed. The district court correctly concluded

that appellant’s damages claims against federal judges were barred by absolute judicial

immunity. See Sindram v. Suda, 986 F.2d 1459, 1460 (D.C. Cir. 1993) (per curiam)

(“Judges enjoy absolute judicial immunity from suits for money damages for all actions

taken in the judge’s judicial capacity, unless these actions are taken in the complete

absence of all jurisdiction.”). Any claims for injunctive relief are frivolous. See 28

U.S.C. § 1915(e)(2)(B)(i); Richards v. Delta Air Lines, Inc., 453 F.3d 525, 531 n.6 (D.C.

Cir. 2006) (“The general rule is that injunctive relief will not issue when an adequate

remedy at law exists.”). Further, appellant’s argument that judicial immunity does not

apply because he is suing for administrative acts is also frivolous. Appellant’s

allegations all stem from the judges’ judicial decisions and the district court cannot

review decisions of another district court or federal appellate court. See Klayman v.

Kollar-Kotelly, No. 12-5340, 2013 WL 2395909, at *1 (D.C. Cir. May 20, 2013) (citing

Jones v. Supreme Ct. of the United States, 405 F. App'x 508 (D.C. Cir. 2010); Sanders

v. United States, 184 F. App'x 13, 14 (D.C. Cir. 2006)). 
United States Court of Appeals

FOR THE DISTRICT OF COLUMBIA CIRCUIT

____________

No. 21-5175 September Term, 2021

Pursuant to D.C. Circuit Rule 36, this disposition will not be published. The Clerk

is directed to withhold issuance of the mandate herein until seven days after resolution

of any timely petition for rehearing or petition for rehearing en banc. See Fed. R. App.

P. 41(b); D.C. Cir. Rule 41.

Per Curiam

FOR THE COURT:

Mark J. Langer, Clerk 

BY: /s/

Daniel J. Reidy 

Deputy Clerk

Page 2
#### Raymond FARLEY and Charles Currie, Relators, v. Honorable Daniel FUTCH, Jr., Judge of the Circuit Court of Broward County, Florida, Respondent.

No. 74-80.

District Court of Appeal of Florida, Fourth District.

Feb. 14, 1974.

Rehearing Denied March 4, 1974.

Prohibition denied.
I 

116TH CONGRESS 

2D SESSION H. R. 7055 

To provide for an increased fine and term of imprisonment for fraud in 

connection with the COVID-19 pandemic, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 28, 2020 

Mr. MEUSER (for himself and Mr. SUOZZI) introduced the following bill; which 

was referred to the Committee on the Judiciary 

A BILL 

To provide for an increased fine and term of imprisonment 

for fraud in connection with the COVID-19 pandemic, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Coronavirus 

5 Scammers, Crooks, and Manipulators Act’’ or the ‘‘SCAM 

6 Act’’. 

7 SEC. 2. MAIL FRAUD AND OTHER FRAUD OFFENSES. 

8 (a) FRAUDS AND SWINDLES.—Section 1341 of title 

9 18, United States Code, is amended by inserting after ‘‘30 

10 years, or both.’’ the following: ‘‘If the violation occurs in 


pamtmann on DSKBC07HB2PROD with BILLS
2 

•HR 7055 IH

1 relation to, or involving any benefit authorized, trans2 ported, transmitted, transferred, disbursed, or paid in con3 nection with the emergency declared on March 13, 2020, 

4 by the President under the Robert T. Stafford Disaster 

5 Relief and Emergency Assistance Act relating to 

6 Coronavirus Disease 2019, such person shall be fined not 

7 more than $1,500,000 or imprisoned not more than 45 

8 years, or both.’’. 

9 (b) FRAUD BY WIRE, RADIO, OR TELEVISION.—Sec10 tion 1343 of title 18, United States Code, is amended by 

11 inserting after ‘‘30 years, or both.’’ the following: ‘‘If the 

12 violation occurs in relation to, or involving any benefit au13 thorized, transported, transmitted, transferred, disbursed, 

14 or paid in connection with the emergency declared on 

15 March 13, 2020, by the President under the Robert T. 

16 Stafford Disaster Relief and Emergency Assistance Act 

17 relating to Coronavirus Disease 2019, such person shall 

18 be fined not more than $1,500,000 or imprisoned not 

19 more than 45 years, or both.’’. 

20 SEC. 3. COUNTERFEIT GOODS AND SERVICES. 

21 Section 2320(b) of title 18, United States Code, is 

22 amended by adding at the end the following: 

23 ‘‘(4) COVID-19.—Any person who commits an 

24 offense under subsection (a) involving a counterfeit 

25 good, which is advertised by the person as having 


pamtmann on DSKBC07HB2PROD with BILLS
3 

•HR 7055 IH

1 the ability to treat, prevent, or cure COVID-19, 

2 shall, in the case of an individual, be fined not more 

3 than $2,500,000, or imprisoned not more than 45 

4 years, or both, or in the case of a person other than 

5 an individual, be fined $5,500,000.’’. 

Æ 


pamtmann on DSKBC07HB2PROD with BILLS
Exhibit 32

March 9,
2012
Via EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549

Re:
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Ladies
and Gentlemen:

In
connection with the Annual Report of ECA Marcellus Trust I (the "Trust") on Form 10-K for the year ended December 31, 2011 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), the undersigned, not in its individual capacity but solely as the Trustee of the Trust, certifies pursuant to 18 U.S.C. 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that to its knowledge:



The
above certification is furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350) and is not being filed as part of the
Form 10-K or as a separate disclosure document.

The Bank of New York Mellon Trust Company, N.A., Trustee for ECA Marcellus Trust IBy:

/s/ MIKE ULRICHMike UlrichVice President and Trust Officer


---



QuickLinks
#### DADE COUNTY BOARD OF PUBLIC INSTRUCTION, as a governmental agency of the State of Florida, et al., Appellants, v. Jerry GOLDSMITH, Appellee.

No. 72-420.

District Court of Appeal of Florida, Third District.

Nov. 14, 1972.

PER CURIAM.

Affirmed.
#### STATE of Louisiana v. Salvadore OVELLA.

No. 61027.

Supreme Court of Louisiana.

Jan. 5, 1978.

In re: Salvadore Ovella applying for writs of certiorari, prohibition, mandamus and stay order. Parish of Jefferson.

Denial of writ set aside as inadvertent. Writ granted and all proceedings stayed.

SANDERS, C. J.,

dissents from granting of writ and the vacating of the denial previously issued.

The petition of the relator in the above entitled and numbered case having been duly considered,

It is ordered that a Writ of Certiorari issue herein, directing the Honorable Frank V. Zacearía, Judge of the 24th Judicial District, Court for the Parish of Jefferson, to transmit to the Supreme Court of Louisiana, on or before the 19th day of January, 1978, the record in duplicate, or a certified copy of the record in duplicate, of the proceedings complained of by the relator herein, to the end that the validity of said proceedings may be ascertained.

It is further ordered that the aforesaid Judge of said Court and the respondent through counsel shall show cause, in this court, on a date to be fixed by this Court why the relief prayed for in the petition of the relator should not be granted.

Denial of writ set aside as inadvertent. Writ granted and all proceedings stayed.

SANDERS, C. J., dissents from granting of writ and the vacating of the denial previously issued.
[Federal Register Volume 62, Number 245 (Monday, December 22, 1997)]
[Rules and Regulations]
[Page 66822]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-33313]


=======================================================================
-----------------------------------------------------------------------

LIBRARY OF CONGRESS

Copyright Office

37 CFR Part 202

[Docket No. 97-8]


Registration of Claims to Copyright: Group Registration of 
Serials

AGENCY: Copyright Office, Library of Congress.

ACTION: Final rule; technical amendment.

-----------------------------------------------------------------------

SUMMARY: The Copyright Office is making a technical amendment to one of 
the addresses designated in the group registration procedures.

EFFECTIVE DATE: December 22, 1997.

FOR FURTHER INFORMATION CONTACT: Kent Dunlap, Principal Legal Advisor 
to the General Counsel, Copyright GC/I&R P.O. Box 70400, Southwest 
Station, Washington, D.C. 20024. Telephone: (202) 707-8380. Telefax: 
(202) 707-8366.

SUPPLEMENTARY INFORMATION: In 1990, the Copyright Office adopted a new 
registration procedure which permitted group registration of serial 
publications under certain conditions. 55 FR 50556 (1990). This 
procedure is part of the regulations of the Copyright Office at 37 CFR 
Chap. II, Secs. 202.3(b)(5) and 202.20(c)(2)(xvii). This document 
amends the address to which the complimentary subscriptions must be 
mailed.

List of Subjects in 37 CFR Part 202

    Claims, Copyright, Registration.

Technical Amendment

    In consideration of the foregoing, the Copyright Office is amending 
part 202 of 37 CFR, chapter II in the manner set forth below.

PART 202--REGISTRATION OF CLAIMS TO COPYRIGHT

    1. The authority citation for part 202 continues to read as 
follows:

    Authority: 17 U.S.C. 702.


Sec. 202.3  [Amended]

    2. Section 202.3(b)(5)(iii) is amended to add ``-4161,'' after 
``20540''.

    Dated: December 17, 1997.
Marilyn J. Kretsinger,
Assistant General Counsel.
[FR Doc. 97-33313 Filed 12-19-97; 8:45 am]
BILLING CODE 1410-30-P
|    |                                                                                                                         |
|----|-------------------------------------------------------------------------------------------------------------------------|
| 1. | I have reviewed this annual report on Form 10-K/A for the fiscal year ended June 30, 2019 of Escalon Medical Corp. |

|    |                                                                                                                                                                                                                                                                                                            |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |

|                        |
|------------------------|
|                        |  |
| Date: October 25, 2019 | /s/    Richard J. DePiano, Jr. |
|                   | Richard J. DePiano, Jr. |
|                   | Chief Executive Officer |
|                   |   |
<PAGE>

                                                                    EXHIBIT 32.2

                      STATEMENT OF CHIEF FINANCIAL OFFICER
         PURSUANT TO SECTION 1350 OF TITLE 18 OF THE UNITED STATES CODE

     Pursuant to section 1350 of Title 18 of the United States Code, I, Robert
M. O'Connor, the Chief Financial Officer of Escalon Medical Corp. (the
"Registrant"), hereby certify that, to the best of my knowledge:

     1.   The Registrant's Form 10-KSB/A Annual Report for the fiscal year ended
          June 30, 2006 fully complies with the requirements of Section 13(a) of
          the Exchange Act; and

     2.   The information contained in this report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Registrant.


Date: October 27, 2006                  /s/ Robert M. O'Connor
                                        ----------------------------------------
                                        Robert M. O'Connor
                                        Chief Financial Officer

     A signed copy of this written statement required by Section 906 of the
Sarbanes-Oxley Act of 2002 has been provided to the Registrant and will be
furnished to the Securities Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<RESTATED>
<CIK> 0000861184
<NAME> WAHLCO ENV. SYSTEMS
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                           2,864
<SECURITIES>                                         0
<RECEIVABLES>                                   10,322
<ALLOWANCES>                                         0
<INVENTORY>                                      2,899
<CURRENT-ASSETS>                                19,591
<PP&E>                                           4,601
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  25,191
<CURRENT-LIABILITIES>                           18,117
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           176
<OTHER-SE>                                     (8,524)
<TOTAL-LIABILITY-AND-EQUITY>                    25,191
<SALES>                                         42,342
<TOTAL-REVENUES>                                49,729
<CGS>                                           34,970
<TOTAL-COSTS>                                   40,540
<OTHER-EXPENSES>                                12,872
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             (1,887)
<INCOME-PRETAX>                                (5,419)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (5,419)
<EPS-PRIMARY>                                   (0.31)
<EPS-DILUTED>                                   (0.31)


</TABLE>